کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
3001585 1180651 2016 11 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
Acyl CoA synthetase 5 (ACSL5) ablation in mice increases energy expenditure and insulin sensitivity and delays fat absorption
ترجمه فارسی عنوان
آسیل کوآ سنتز 5 (ACSL5) فرسایش در موش مصرف انرژی و حساسیت به انسولین و تاخیر جذب چربی را افزایش می دهد
کلمات کلیدی
جذب چربی رژیم غذایی؛ Acyl-CoA؛ ACSL؛ روده؛ کبد؛ FGF21ACSL، زنجیره طولانی آکسیل-CoA سینتتاز؛ ACSL5 - / -، موش ها با تخریب جهانی ACSL5؛ FGF21، عامل فیبروبلاست رشد 21؛ UCP1، پروتئین جدا شدن 1؛ PPAR، proliferator پراکسیوم فعال فعال می شود
موضوعات مرتبط
علوم زیستی و بیوفناوری علم عصب شناسی سیستم های درون ریز و اتونومیک
چکیده انگلیسی


• Role of acyl CoA synthetase 5 (ACSL5) in systemic metabolism was studied in an ACSL5 deficient mouse.
• ACSL5 deficiency reduced total ACSL activity in liver, intestine, and brown adipose tissue.
• ACSL5 deficient mice had increased hepatic and circulating FGF21 expression and energy expenditure.
• ACSL5 deficient mice demonstrated delayed triglyceride absorption.

ObjectiveThe family of acyl-CoA synthetase enzymes (ACSL) activates fatty acids within cells to generate long chain fatty acyl CoA (FACoA). The differing metabolic fates of FACoAs such as incorporation into neutral lipids, phospholipids, and oxidation pathways are differentially regulated by the ACSL isoforms. In vitro studies have suggested a role for ACSL5 in triglyceride synthesis; however, we have limited understanding of the in vivo actions of this ACSL isoform.MethodsTo elucidate the in vivo actions of ACSL5 we generated a line of mice in which ACSL5 expression was ablated in all tissues (ACSL5−/−).ResultsAblation of ACSL5 reduced ACSL activity by ∼80% in jejunal mucosa, ∼50% in liver, and ∼37% in brown adipose tissue lysates. Body composition studies revealed that ACSL5−/−, as compared to control ACSL5loxP/loxP, mice had significantly reduced fat mass and adipose fat pad weights. Indirect calorimetry studies demonstrated that ACSL5−/− had increased metabolic rates, and in the dark phase, increased respiratory quotient. In ACSL5−/− mice, fasting glucose and serum triglyceride were reduced; and insulin sensitivity was improved during an insulin tolerance test. Both hepatic mRNA (∼16-fold) and serum levels of fibroblast growth factor 21 (FGF21) (∼13-fold) were increased in ACSL5−/− as compared to ACSL5loxP/loxP. Consistent with increased FGF21 serum levels, uncoupling protein-1 gene (Ucp1) and PPAR-gamma coactivator 1-alpha gene (Pgc1α) transcript levels were increased in gonadal adipose tissue. To further evaluate ACSL5 function in intestine, mice were gavaged with an olive oil bolus; and the rate of triglyceride appearance in serum was found to be delayed in ACSL5−/− mice as compared to control mice.ConclusionsIn summary, ACSL5−/− mice have increased hepatic and serum FGF21 levels, reduced adiposity, improved insulin sensitivity, increased energy expenditure and delayed triglyceride absorption. These studies suggest that ACSL5 is an important regulator of whole-body energy metabolism and ablation of ACSL5 may antagonize the development of obesity and insulin resistance.

Figure optionsDownload as PowerPoint slide

ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Molecular Metabolism - Volume 5, Issue 3, March 2016, Pages 210–220
نویسندگان
, , , , , , , , , ,